TF and HIV infectious disease: While patients with HIV infection were not eligible for participation in the study, findings of our exploratory post hoc analysis indicate that low-grade inflammation and boosted LPS-induced monocyte TF production were mainly restricted to HBV/HCV-positive patients (Fig. 4).